Stroke AI Tools: Imaging Triage and Transfer Checks
Evaluate stroke AI tools by intended use, FDA status, CT and CTA workflow, alert routing, transfer coordination, privacy, and local validation.
Representative source image: official Brainomix 360 Stroke product page.
Quick answer: Stroke AI tools can support CT, CTA, perfusion, LVO, hemorrhage, ASPECTS, mobile alerting, and transfer coordination, but they should remain specialist-reviewed. Buyers should verify the exact FDA-cleared or validated module, imaging input, intended use, alert workflow, privacy controls, local performance, and downtime plan before relying on outputs in acute stroke care.
Who this guide is for
Stroke centers, emergency departments, neuroradiology teams, transfer networks, telestroke programs, and health-system AI governance committees.
What makes this workflow different
Stroke AI can change urgent imaging review, specialist activation, thrombectomy transfer, and patient-routing decisions, so teams need module-specific checks rather than platform-level claims.
What to verify before using it
Match each stroke AI module to its cleared or validated indication, modality, anatomy, software version, and geography.
Map CT, CTA, CTP, MRI, PACS/RIS, mobile notification, telestroke, transfer-center, and EHR data flows before launch.
Define who receives alerts, who confirms findings, how transfers are activated, and what happens when AI output conflicts with radiology or neurology review.
Validate local performance for scanner mix, ASPECTS or LVO agreement, false alerts, missed cases, door-in-door-out time, thrombectomy activation, and equity across sites.
Review PHI handling, mobile message content, retention, audit logs, downtime procedures, and post-deployment monitoring for every enabled module.
Risk level and safe use
Medical risk
High
Best first step
Write the workflow in one sentence, decide who reviews the AI output, and test with a small controlled pilot before expanding.
Recommended posture
Use AI as supervised workflow support. Verify sources, privacy, human review, and regulatory fit before relying on outputs.
Source-backed products for this workflow
These profiles are not rankings. They are starting points for checking vendor claims, privacy terms, FDA or regulatory posture, evidence, and workflow fit.
Brainomix describes Brainomix 360 Stroke as an FDA-cleared and CE-marked collection of stroke imaging tools; company FDA-clearance announcements cover e-ASPECTS and non-contrast CT core-volume assessment, while Brainomix patient-data materials describe temporary server processing, pseudonymized cloud access in some workflows, and hospital-directed retention.
Best for
Hospitals and regional stroke networks that need AI-assisted imaging triage, ASPECTS support, LVO/collateral assessment, and transfer coordination under specialist review.
First check
Which Brainomix 360 Stroke modules are in scope, such as e-ASPECTS, e-CTA, Triage Stroke, core-volume, e-MRI, or mobile notifications.
Avicenna.AI describes CINA-ASPECTS as a neurovascular imaging tool that analyzes non-enhanced head CT to calculate ASPECTS, provide heat maps, and support stroke severity assessment; FDA materials list 510(k) K233342 for CINA-ASPECTS and state it is not intended for primary CT interpretation, with validation and use limits around known MCA or ICA occlusion, adult patients over 21, specific scanner manufacturers, and acute brain ischemia within 12 hours from last known well.
Best for
Stroke programs that need standardized ASPECTS support, region-level visualization, and radiologist or stroke-physician review within an acute stroke pathway.
First check
Whether CINA-ASPECTS clearance, software version, age limits, scanner manufacturers, and geography match the planned stroke workflow.
RapidAI describes a clinical AI and enterprise imaging platform, including stroke, vascular, hemorrhage, and aortic workflows; its materials describe FDA-cleared modules, edge/cloud deployment choices, Data Privacy Framework terms, and healthcare security certifications.
Best for
Hospitals evaluating stroke, vascular, aortic, hemorrhage, or other imaging workflows that need integrated alerts and care coordination.
First check
Which RapidAI module is in scope and whether its clearance matches the exact modality, anatomy, and intended use.
Viz.ai states its platform is driven by more than 50 FDA-cleared algorithms and supports imaging-driven care coordination; its trust center frames security and privacy diligence for clinical-data deployments.
Best for
Teams that need rapid disease detection alerts and coordinated response pathways.
First check
Which algorithms are FDA-cleared for your use case.
Sources
4 official sources
Official source trail for this workflow
Open these vendor, documentation, privacy, or regulatory sources before relying on product claims, especially for FDA status, PHI handling, deployment model, and intended use.
Find the best AI for medical workflows by matching the tool to documentation, questions, diagnosis support, research, coding, billing, imaging, or practice operations.
Understand AI for medical diagnosis, including validation evidence, FDA status, clinical supervision, and why patient-specific diagnosis should not rely on general chatbots.
